2.3 CSF Physiology

ABIM Neurocritical Care Subspecialty Certification Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility, Practice Pathway, and the IM Training Route 1.3 Format, Scoring, Pearson VUE, and Score Reports 1.4 How to Use This Independent Study Guide

2 ICU Neurologic Exam, Cerebral Physiology, and CSF

2.1 Neurological Examination in the ICU 2.2 Cerebral Physiology, ICP, CBF, and Autoregulation 2.3 CSF Physiology

3 Core Neuropharmacology

3.1 Osmotic Agents 3.2 Anti-Seizure Drugs 3.3 Anesthetics, Sedatives, Analgesia, and Paralytics 3.4 Antihypertensives, Vasopressors, and Inotropes

4 Reperfusion Drugs, Airway, and Ventilation

4.1 Thrombolytics, Anticoagulants, and Antiplatelets 4.2 Reversal of Anticoagulation After Acute Hemorrhage 4.3 Airway Management and Tracheostomy 4.4 Mechanical Ventilation

5 Hemodynamics and Shock

5.1 Hemodynamic Monitoring 5.2 IABP, Temporary VADs, LVAD, and ECMO 5.3 Diagnosis and Management of Shock

6 Nutrition, Temperature, and ICU Prophylaxis

6.1 Nutrition (01.J) 6.2 Temperature Control (01.K) 6.3 ICU Prophylaxis, Delirium, and Early Mobility (01.L)

7 General Trauma

7.1 Emergency Evaluation of Polytrauma, Chest, and Abdominal Trauma 7.2 Long-Bone Fractures and Fat Embolism 7.3 Burns, Electrical Injury, and Hanging/Strangulation

8 Pulmonary Critical Care

8.1 Pulmonary Physiology and ARDS (01.N.1–2) 8.2 PE, Pneumonia, and Pulmonary Edema (01.N.3, 7–8) 8.3 COPD, Asthma, PAH, and Bronchoscopy Basics (01.N.4–6, 9)

9 Cardiovascular Critical Care

9.1 Cardiovascular Physiology, Stress Cardiomyopathy, ACS, and Valves 9.2 Arrhythmias and Pacing 9.3 Acute Aortic Dissection and Cardiac Ultrasound

10 Renal and Infectious Disease

10.1 AKI, RRT, and Renal Drug Dosing 10.2 Acid-Base and Electrolyte Disorders 10.3 Severe Sepsis, Septic Shock, and Infective Endocarditis 10.4 Antimicrobial Use and Infection in the Immunosuppressed

11 Endocrine and Salt-Water Disorders

11.1 Pituitary Apoplexy, DI, and Panhypopituitarism (01.R.1–4) 11.2 SIADH and Cerebral Salt Wasting (01.R.5–6) 11.3 Thyrotoxicosis, Myxedema, Adrenal Crisis, and Dysglycemia (01.R.7–9)

12 Gastrointestinal Critical Care

12.1 GI Physiology, Acute Abdomen, Bleed, Ileus, and Perforation (01.S.1–5) 12.2 Mesenteric Ischemia and Abdominal Compartment Syndrome (01.S.6–7) 12.3 Fulminant Liver Failure, Cirrhosis Decompensation, and Hepatic Dosing (01.S.8–10)

13 Hematologic Disorders

13.1 Anemia, Transfusion, Thrombocytopenia, Coagulopathy, and DIC (01.T.1–4) 13.2 VTE in the Neuro ICU (01.T.5) 13.3 Chemo/Immune, SCT, CAR-T, Sickle Cell, and TMA (01.T.6–10)

14 Neuroimaging

14.1 CT of Brain and Spine 14.2 MRI and CT/MR Perfusion 14.3 Noninvasive Angiography and Catheter Angiography

15 EEG, EMG, and CSF Analysis

15.1 EEG, Standard and Processed (02.B) 15.2 Basic EMG Interpretation (02.G) 15.3 CSF Analysis (02.H)

16 ICP, TCD, and Multimodality Monitoring

16.1 ICP Monitoring (02.C) 16.2 Transcranial Doppler (02.D) 16.3 Brain-Tissue Oxygen and Multimodality Monitoring (02.E–F)

17 Brain Death and Bedside Procedures

17.1 Brain Death Prerequisites and Clinical Exam (02.I) 17.2 Apnea Testing and Ancillary Studies (02.I) 17.3 Vascular Access, Thoracic Echo, and Lung Ultrasound (02.J–L)

18 Coma, Anoxia, and Intracranial Hypertension

18.1 Coma and Other States of Altered Consciousness (03.A) 18.2 Global Anoxia-Ischemia and Post-Resuscitation Encephalopathy (03.A.1) 18.3 Toxidromes, ICU Delirium, and Hypertensive Encephalopathy (03.A.2–4) 18.4 Intracranial Hypertension as a Disease State (03.B)

19 Acute Ischemic Stroke

19.1 IV Reperfusion Therapy (03.C.3) 19.2 Mechanical Thrombectomy Windows and Imaging Selection (03.C.3) 19.3 Malignant Hemispheric Infarction and Basilar Artery Occlusion (03.C.1–2)

20 Intraparenchymal Hemorrhage

20.1 Intracerebral Hematoma (03.D.1) 20.2 Cerebellar Hematoma (03.D.2) 20.3 Intraventricular Hemorrhage (03.D.3)

21 SAH, CVST, and Spinal Cord Infarction

21.1 Aneurysmal Subarachnoid Hemorrhage (03.E.1) 21.2 Non-Aneurysmal SAH (03.E.2) 21.3 Cerebral Venous Sinus Thrombosis (03.F) 21.4 Spinal Cord Infarction (03.G)

22 Vascular Anomalies and Traumatic Brain Injury

22.1 Unruptured Aneurysm, Cavernoma, AVM, and Dural AVF (03.H) 22.2 Diffuse Axonal Injury and Cerebral Contusions (03.I.1–2) 22.3 Epidural Hematoma, Subdural Hematoma, and Penetrating Injury (03.I.3–4, 7) 22.4 Arterial Dissection and Carotid-Cavernous Fistula (03.I.5–6)

23 Spine, Hydrocephalus, and CNS Infection

23.1 Spinal Cord Injury, Central Cord, and Neurogenic Shock (03.J) 23.2 Unstable Spine Fractures (03.K) 23.3 Hydrocephalus and CSF Diversion (03.L) 23.4 Acute CNS Infections (03.M)

24 Seizures and Neuromuscular Emergencies

24.1 Status Epilepticus and Seizures (03.N) 24.2 Guillain-Barré Syndrome (03.O.1) 24.3 Myasthenic Crisis (03.O.2) 24.4 Motor Neuron Disease, Acute Myopathies, Rhabdomyolysis, and CINM (03.O.3–6)

25 Inflammatory Disease, Neuro-Oncology, and Special Populations

25.1 Fulminant Demyelinating Diseases (03.P) 25.2 Autoimmune Encephalitis and Acute Autonomic Hyperactivity (03.Q–R) 25.3 Neuro-Oncology and Treatment Complications (03.S) 25.4 Pregnancy/Post-Partum, Post-Transplant, and Pediatric Patients (03.T–U)

26 Neurosurgical and Perioperative Complications

26.1 Postoperative Seizures, Hemorrhage, Ischemia, and Hyperperfusion (04.A, C, D, H) 26.2 Infection, CSF Leak, and Pneumocephalus (04.B, E, F) 26.3 Complications of EVD and Lumbar Drain (04.G, I)

27 Ethics, Prognostication, and Organ Donation

27.1 Communication, Decision-Makers, Advance Directives, and DNR (05.A, B, G) 27.2 Uncertainties of Prognostication and the Self-Fulfilling Prophecy (05.C) 27.3 Palliative Care, Withdrawal, Withholding, and Futility (05.D–F) 27.4 Donation After Cardiac Death and Care of the Organ Donor (05.H–I)

2.3 CSF Physiology

Key Takeaways Explain This Topic AI

Choroid plexus produces about 20 mL/h of CSF (~500 mL/day) into a total adult CSF volume of about 150 mL.

Absorption is primarily through arachnoid granulations into the venous sinuses.

Communicating hydrocephalus is an absorption-pathway problem; obstructive hydrocephalus is a blockage inside the ventricular route.

Lumbar puncture and lumbar drainage are contraindicated when a mass lesion or obstructive hydrocephalus could precipitate herniation.

Xanthochromia from bilirubin typically becomes detectable about 12 hours after subarachnoid hemorrhage and can persist for about two weeks.

Last updated: September 2026

CSF Physiology

Quick Answer: CSF production is about 20 mL/h ( ~500 mL/day ) by the choroid plexus . Total adult volume is about 150 mL . Absorption is mainly at arachnoid granulations . Obstructive hydrocephalus blocks the ventricular pathway; communicating hydrocephalus is usually failed absorption. Do not perform a lumbar puncture or place a lumbar drain when a mass lesion or obstructive hydrocephalus could cause herniation. Xanthochromia is timed at about 12 hours after SAH.

Cerebrospinal fluid is not an inert lubricant. It is a circulating compartment you can drain, infect, sample, and accidentally herniate through. Independent ExamFinch teaching in this section covers CSF physiology listed under Principles of neurocritical care in the ABPN Content Specifications. Detailed CSF laboratory interpretation (cells, protein, PCR) sits with diagnostic studies later in this guide; here the job is production, volume, barriers, hydrocephalus mechanics, and when a needle in the back is unsafe.

Production, volume, and absorption

Choroid plexus in the lateral, third, and fourth ventricles secretes most CSF. Textbook rates are about 20 mL/h , which is about 500 mL/day (20 × 24 = 480 mL, conventionally rounded to 500). Adult total CSF volume is about 150 mL , of which on the order of 25 mL sits in the ventricles and the rest in the cranial and spinal subarachnoid space. At 500 mL/day through a 150 mL tank, the fluid turns over roughly three to four times per day . That is why an undrained obstruction climbs so fast, and why an external drain can remove a large fraction of daily production.

CSF flows from the lateral ventricles through the foramina of Monro into the third ventricle, down the cerebral aqueduct into the fourth ventricle, then out the foramina of Luschka and Magendie into the cisterns. From there it bathes the convexity and spinal thecal sac. Absorption is primarily through arachnoid granulations (Pacchionian granulations) into the dural venous sinuses, driven by the pressure gradient from CSF to venous blood. Accessory routes (nerve-root sleeves, lymphatics) exist but are not the exam's first answer.

Quantity Adult teaching number
Production rate ~ 20 mL/h
Daily production ~ 500 mL/day
Total CSF volume ~ 150 mL
Ventricular share (order of magnitude) ~ 25 mL
Daily turnover ~3–4 times the total volume

Carbonic anhydrase inhibitors (acetazolamide) and some drugs can slow choroid secretion; they do not replace a drain when the aqueduct is blocked. Overproduction is rare (choroid plexus papilloma) and is still classified with the communicating picture because the ventricles talk to each other.

Blood–brain and blood–CSF barriers

The blood–brain barrier (BBB) is capillary endothelium with tight junctions, supported by pericytes and astrocyte end-feet. It keeps plasma proteins, many polar drugs, and circulating immune cells from freely entering brain extracellular fluid. The blood–CSF barrier is different anatomy: choroid capillaries are actually fenestrated, and the tight junctions sit in the choroid epithelium that secretes CSF. Inflammation, ischemia, and hyperosmolar contrast can open these barriers. That is why some antibiotics need inflamed meninges to reach useful CSF levels, and why a protein-rich CSF does not automatically mean a lumbar puncture was performed in the wrong place—it may mean a broken barrier or a high serum protein. For this physiology chapter, remember two barriers, two locations , not a single generic "brain filter."

Communicating versus obstructive hydrocephalus

Obstructive (non-communicating) hydrocephalus means CSF cannot pass a point inside the ventricular route: colloid cyst at a foramen of Monro, aqueductal stenosis, cerebellar mass compressing the fourth ventricle, or blood casting the aqueduct. Upstream ventricles enlarge. A lumbar drain or lumbar puncture then removes fluid from a downstream compartment while the ventricles remain tense—the recipe for downward herniation .

Communicating hydrocephalus means the ventricles still communicate with each other and with the spinal subarachnoid space, but absorption at the granulations is impaired (classic after subarachnoid hemorrhage or meningitis ) or, rarely, production is excessive. All ventricles enlarge. A lumbar drain can share the load because the pathway to the lumbar cistern is open. Normal-pressure hydrocephalus is a chronic communicating picture and is not an acute herniation syndrome.

Feature Obstructive Communicating
Block site Inside ventricles or outlets Usually arachnoid granulations (absorption)
Typical ICU causes Mass, aqueductal clot, posterior-fossa swelling SAH, meningitis
Ventricles Upstream dilatation, possible trapped ventricle Panventricular enlargement
EVD First-line diversion and ICP measurement Also used; treats pressure and blood-stained CSF

Lumbar drain / LP Unsafe if the pathway is blocked or a mass is shifting May be used when imaging shows open pathways and no mass effect

EVD versus lumbar drain physiology

An external ventricular drain (EVD) is a catheter in a lateral ventricle. It can measure ICP and divert CSF proximal to most obstructions, which is why it is the tool for acute obstructive hydrocephalus and for many ICH/IVH and SAH patients. Height of the drip chamber relative to the tragus (or external auditory canal) sets the hydrostatic pop-off; complications of overdrainage and infection belong to a later neurosurgical-complications chapter, but the physiology is already here: drain too much, and you can collapse ventricles or provoke upward herniation in a posterior-fossa mass.

A lumbar drain sits in the lumbar subarachnoid space. It unloads the thecal sac . That helps selected communicating hydrocephalus, CSF leaks after endoscopic skull-base surgery, and some spinal-cord perfusion strategies. It does not decompress trapped ventricles. If you place a lumbar drain in obstructive hydrocephalus, you can suck the lumbar cistern dry while the supratentorial pressure remains high— tonsillar herniation physiology.

Lumbar puncture: contraindications, opening pressure, xanthochromia

Do not perform LP when imaging (or a high-probability bedside picture) shows a mass lesion with shift , obstructive hydrocephalus , or an uncal/tonsillar herniation pattern. Other classic stops are coagulopathy, infection at the needle site, and suspected lumbar epidural abscess in some pathways. A normal-looking mental status does not make LP safe if CT shows a posterior-fossa mass.

Opening pressure is measured in the lateral recumbent position with the legs extended and the patient relaxed, using a manometer. Sitting-position pressures are not interchangeable. Adult opening pressure is commonly about 6–20 cm H2O ; many sources treat >25 cm H2O as elevated in non-obese adults. Conversion: 1 mmHg ≈ 1.36 cm H2O , so an ICP of 15 mmHg is about 20 cm H2O . High opening pressure with headache and papilledema, without a mass, points you toward idiopathic intracranial hypertension or cerebral venous thrombosis rather than toward a "therapeutic large-volume tap" as the first move if imaging is incomplete.

Xanthochromia is yellow discoloration of centrifuged CSF from bilirubin generated in vivo by heme oxygenase acting on hemoglobin. That enzymatic step takes time: clinical practice that uses LP to catch CT-negative SAH waits about 12 hours after headache onset so bilirubin can form. Oxyhemoglobin can appear earlier and is less specific. Visual inspection misses faint pigment; spectrophotometry is more sensitive where it is available. Once present, xanthochromia can last up to about two weeks . A bloody tap from a traumatic needle shows erythrocytes that decrease in successive tubes and no bilirubin if the blood is minutes old—do not call that xanthochromia.

Worked timing: headache at 08:00, CT negative at 10:00. An LP at 11:00 can still miss bilirubin. An LP after 20:00 (12 hours from onset) is the physiologically timed test for xanthochromia. That clock does not replace CTA or DSA when the pre-test probability of aneurysm remains high.

Independent practice at /practice/abim-neurocritical-care should check whether you refuse the unsafe LP, pick EVD for obstruction, and wait for the 12-hour xanthochromia window rather than inventing a same-hour bilirubin result.